Safety Rates Drug Report: ETOPOSIDE. Disease recurrence adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: ETOPOSIDE. Injury: Disease recurrence Quarter: 2016Q3

|< 1/2 << Previous Page Page 2

Total Records: 34 Number of Pages: 2

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
125296161	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160706	JP
125296181	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160706	JP
125296201	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160706	JP
125296241	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160706	JP
125296271	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160706	JP
125296321	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160706	JP
125296481	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160706	JP
125403281	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160708	BE
126891062	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160928	TW
126925681	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160829	US
126931881	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160829	JP
127153611	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160906	US
127216531	ETOPOSIDE.	Disease recurrence	AVENTIS	6.00 YR	M	0	20160907	GR
127229781	ETOPOSIDE.	Disease recurrence	CIPLA	0.00		0	20160908	US

|< 1/2 << Previous Page Page 2

Total Records: 34 Number of Pages: 2

Execution Time: 0.17414593696594 seconds (ucode:5138600). Developed by: James D. Barger